Home/Benitec Biopharma/Jerel Banks, M.D., Ph.D.
JB

Jerel Banks, M.D., Ph.D.

Chief Executive Officer & Chairman of the Board

Benitec Biopharma

Benitec Biopharma Pipeline

DrugIndicationPhase
BB-301Oculopharyngeal Muscular Dystrophy (OPMD)Phase 1b/2a